- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
- IMCD completes acquisition of remaining 30% of Signet Excipients Private Limited
More ▼
Key statistics
On Wednesday, IMCD NV (IMCDY:PKL) closed at 74.76, -17.65% below its 52-week high of 90.78, set on Mar 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 75.28 |
---|---|
High | 75.31 |
Low | 74.76 |
Bid | -- |
Offer | -- |
Previous close | 75.61 |
Average volume | 3.24k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 1.21 USD |
---|---|
Annual div yield (ADY) | 1.62% |
Div ex-date | May 16 2024 |
Div pay-date | Jun 05 2024 |
Data delayed at least 15 minutes, as of May 22 2024 20:59 BST.
More ▼